Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$3.7M
FY22
$3.0M
FY23
$3.3M
FY24
$2.5M
FY25
By Funding Mechanism
R01
8
F30
1
R00
1
R03
1
R21
1
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Visceral Heterotaxy. Strongest funded area: Basic Science. Largest gap: Clinical Research.
Clinical ResearchTrials Active, No NIH Grants
1 clinical trial registered but no NIH-funded clinical or translational research grants found for visceral heterotaxy. Trials may be industry-sponsored or funded through non-NIH sources.
Clinical ResearchPublished, Not NIH-Funded
18 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for visceral heterotaxy. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(8 grants)
These grants mention Visceral Heterotaxy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(8)
OtherR01Active
A multidisciplinary approach to understanding feedback and clustering in PCP signaling
Axelrod, Jeffrey et al.·STANFORD UNIVERSITY·STANFORD, CA
